Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PULM Short Term Catalysts (anytime now-Q1 2021)
1) PUR1900 FDA Type C Meeting -- likely bullish news coming out of there regarding P3 Trial Setup with Cipla -- perhaps even EUA but speculation only on such comment
2) PUR1900 new updated contract terms with CIPLA (more favorable to Pulmatrix assumed, likely retain US + Europe rights)
2) FEND New Studies/Data & Pathway to Global Launch -- India Manufacturing Pathway -- Potential Partnership with larger manufacturing partners/world organizations
3) PUR1800 Update with J&J - COPD Trials Start
4) Potential wildcard of JnJ inhaled vaccine development utilizing iSPERSE-- and/or other companies such as Pfizer/AstraZeneca (speculative comment yet foundation exists)
5) PUR3100 Migrane pre-clinical design update -- including who we are partnered with in such endeavor...
6) Nocion update of using iSPERSE on any of their portfolio
7) Unexpected partnerships/licensing deals either via therapeutic or vaccine(s) with iSPERSE enabled version
Inhaled Delivery Platform (iSPERSE) during a respiratory pathogen pandemic -- partnered with Johnson and Johnson and Cipla (largest inhaler player in India) -- FDA Fast Tracked & MHRA Approvals. Spin-off of anti-contagion and prophylactic product with aim of introducing a new hygiene class as common as soap. All this with cash on hand and no debt.
You couldn't draw up a more opportunistic backdrop for Pulmatrix to enter the market. The only thing which isn't screaming iSPERSE is the future is the current stock price.
$PULM
**BUY here @ 1.18x1.19 hand over fist IMO**
$PULM
PT $100++ in 2021.
$PULM
IMO
Hit the gas pedal, Pulmatrix.
$PULM
$PULM $1.33x$1.34
Damn nice result here...
$PULM FEND
$PULM PUR1900 -- iSPERSE enabled inhaled version of JnJ Itraconazole product which is current / limited best in class solution
2017 QIDP Designation: (5 year market exclusivity)
oindpnews.com/2017/10/pulma...
2018: Trial results significant increased efficacy at less dosage compared to oral Itraconazole -- clinical board developed
2019: Cipla (largest generic inhalation share in India) and Pulmatrix ink deal to co-develop and launch Pulmazole
pharmaceutical-technology.c...
2019: Pulmatrix activates multi-site global trials with Cipla
2020: FDA Grants Fast Track for Pulmazole
prnewswire.com/news-release...
COVID Era -- Trials paused & Cipla Deal Renegotiated -- Pulmatrix potentially regains U.S. and Western World full rights...
And the real kicker -- Current Pulmatrix CEO, Ted Raad, on the launch team of the original Itraconazole go to market (brought in after PUR1800 deal)
2021 January Type-C meeting with the FDA...
$1.5B U.S. Market
Only non "PUR" product - branded Pulmazole..
Much more here..
$PULM PUR1800
$JNJ buys RespiVert in 2010 for ~$150M to enter into Kinases Inhibitor Space Early -- which was developed at Imperial College, London.
http://www.pharmatimes.com/news/j_and_j_buys_uk_biotech_respivert_983156
$JNJ Studies and determines RespiVert one of their leading platforms for COPD & Lung Cancer
$JNJ in 2017 gives Pulmatrix full underlying rights to develop and commercialize into PUR1800, an iSPERSE enabled version of RespiVert Technology
"Under the terms of the agreement, which covers both respiratory and oncology uses of the drug candidates, Pulmatrix will assume all development and commercialization activities worldwide"
https://ir.pulmatrix.com/2017-06-13-Pulmatrix-Licenses-Novel-Drug-Candidates-from-RespiVert-Ltd-a-wholly-owned-subsidiary-of-Janssen-Biotech-Inc
$JNJ and $PULM in 2020 (1/2/2020) Pulmatrix re-licensees PUR1800 back to $JNJ with $100M in cash milestone to fund clinical trials (talk about a power play with the largest pharma company in the world)
https://www.prnewswire.com/news-releases/pulmatrix-announces-kinase-inhibitor-licensing-agreement-with-lung-cancer-initiative-at-johnson--johnson-300980456.html
Q2 Business Update: MHRA Approval and trial(s) happening in the U.K. -- where this all started.
Safe to say JnJ finds iSPERSE valuable :)
$PULM
Let's do this, $PULM
Added 1.01-1.02;
$PULM
Just being the boy who cried wolf; iSPERSE has the ability to turn any API (active pharmaceutical ingredient) from an oral capsule with low efficacy and larger side effects into a more efficient inhaled version.
iSPERSE Will:
1) Make current best in drugs cheaper, and more safe
2) Enable new treatment options for previously too risky drug concentrations via oral capsules
3) Open up the world of inhaled vaccines (if not the leader, one of the leaders)
4) Bring new solutions to previously unmet medical needs
Think about the fact that JnJ gave Pulmatrix the full rights to develop and commercialize their leading candidate for Lung Cancer, RV1162. That's how much JnJ believes in iSPERSE.
Price is being used to throw people off the trail. Price will stay depressed until it abruptly moves higher, jmo.
$PULM
Expand your horizon a little bigger.
$PULM
FEND Newswire:
https://www.prnewswire.com/news-releases/sensory-cloud-launches-fend-a-calcium-fortified-hygiene-proven-to-reduce-airborne-respiratory-droplets-not-captured-by-surgical-masks-301154467.html
https://www.fastcompany.com/90565565/i-tested-a-harvard-designed-nasal-spray-to-help-stop-the-spread-of-covid-19
$PULM
Time for the show
$PULM
Last day to Load before FEND Launch + Other news incoming (?)
$PULM
Looking for 100x+ return here at Pulmatrix. FEND + iSPERSE (PUR1800/PUR1900/Inhaled Vaccine (?)) will be worldwide news.
$PULM
Edwards on Fox32 Chicago:
https://www.fox32chicago.com/video/860559
$PULM
Okay next week should be the launch of FEND -- from Edwards mouth himself.
https://www.fox32chicago.com/video/860559
$PULM
Yeah -- agreed, looks like that's a shell company scamming the penny world.
On the contrary, FEND is a new class in hygiene developed by a brilliant scientist.
Thought FEND was going to launch this week; should be about now...
It will generate the interest, needs to be available!!
$PULM
www.hellofend.com -- launch is scheduled for today (I believe).
$PULM
#BeReady $PULM
FEND -- Available 10/5! Starts shipping on Monday!
$PULM
$PULM -- Let's go.
Big news today; market ignoring for now. It won't for much longer.
$PULM
Time for loading increasingly running out... mega-run time.
$PULM
FEND arriving at doorsteps next week.
$PULM
O_o okay... well quite likely you won't be a buyer npnp.
(Email from Sensory Cloud Enclosed)
Thank you so much for your recent purchase of FEND, the new calcium enriched nasal saline for cleansing our airways of airborne particulate matter.
I am really delighted to announce that your FEND product order will be shipping in the coming weeks! You can expect to receive your product within the second week of October, but just to be sure, we will send you a personal message the day that your product ships.
We have also submitted two new scientific articles with data from several human volunteer hygiene studies in the USA, involving around a hundred healthy children, adults and COVID-positive individuals. We will make sure to let you know as soon as they publish!
We are committed to bringing a new level of quantification to human hygiene with a special focus on the air we breathe.
We are also committed to access. Each administration of FEND will cost — on regular daily use — around 10 cents. And we are actively developing partnerships in developing world countries where we hope the cost per dose will be even lower.
Don’t hesitate to reach out with any questions. Otherwise we look forward to reconnecting in October!
David Edwards & The FEND Team
$PULM
Yes (!) - got an email that they have submitted publications on CV-19 case-studies amongst different age groups -- and the 2nd week of October (2 weeks from now) shipments should be arriving.
$PULM
Nice timing; explosion coming. Don't sell too early!
$PULM
Pulmatrix New Patent Granted - DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES
https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2809666/summary.html
$PULM
Also... interesting timing PULM releases a pipeline update the day before JnJ releases P3 Covid Vaccine start.
Things that make you go hmm...
$PULM